Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 1,442,282 |
|
|||||
| News | - | ||||||
| Day High | 28.99 | Low High |
|||||
| Day Low | 27.30 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cullinan Therapeutics Inc | CGEM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 1.09 | 4.04% | 28.10 | 16:36:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 27.54 | 27.30 | 28.99 | 28.10 | 27.01 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15,649 | 1,442,282 | US$ 28.01 | US$ 40,404,933 | - | 7.64 - 29.12 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:19:26 | 4 | US$ 28.89 | USD |
Cullinan Therapeutics (CGEM) Options Flow Summary
Cullinan Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.21B | 43.07M | - | 0 | -153.16M | -3.56 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cullinan Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CGEM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.69 | 29.12 | 16.53 | 24.48 | 2,318,205 | 11.41 | 68.36% |
| 1 Month | 17.02 | 29.12 | 15.20 | 20.91 | 1,102,470 | 11.08 | 65.10% |
| 3 Months | 18.44 | 29.12 | 14.98 | 19.35 | 667,729 | 9.66 | 52.39% |
| 6 Months | 9.30 | 29.12 | 7.64 | 16.88 | 460,716 | 18.80 | 202.15% |
| 1 Year | 9.78 | 29.12 | 7.64 | 14.77 | 350,030 | 18.32 | 187.32% |
| 3 Years | 32.80 | 37.60 | 7.30 | 15.38 | 288,419 | -4.70 | -14.33% |
| 5 Years | 42.00 | 59.85 | 7.30 | 17.71 | 289,390 | -13.90 | -33.10% |
Cullinan Therapeutics Description
| Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. |
